Renalytix plc

After a long wait, Renalytix AI plc was finally granted de novo authorization from the US Food and Drug Administration for its AI-powered prognostic blood test, KidneyIntelX.dkd, which identifies e

Listen to the podcast here: Open Media 'Training' People To Live Healthier Lives Experts foresee the digital therapeutics market growing to $6bn-$9bn by 2025, driven in part by tech-empowered consumer

Renalytix AI , the developer of the KidneyIntelX kidney disease prognosis platform, is partnering with the American Diabetes Association to improve early diagnosis and treatment of kidney disease in p

While the US Centers for Medicare and Medicaid Services has postponed implementing the Medicare Coverage of Innovative Technology (MCIT) rule until at least December, a health analyst says concerns ra